FDA grants ODD to Nexcella's multiple myeloma treatment

24th August 2023 Uncategorised 0

The drug is currently being assessed in a phase 1b/2a clinical trial

More: FDA grants ODD to Nexcella's multiple myeloma treatment
Source: News